Insights

Innovative Therapeutic Focus Sparrow Pharmaceuticals specializes in targeted cardiometabolic therapeutics with a focus on novel HSD-1 inhibitors like clofutriben, addressing a significant unmet need in diabetes and metabolic disorders, presenting opportunities to collaborate on cutting-edge treatments.

Strong Funding Momentum Recently securing $95 million in Series B funding highlights the company's robust financial backing and growth potential, making it an attractive partner for expanding clinical research and commercial distribution efforts.

Strategic Collaborations Partnerships with leading academic institutions like Oxford and Sheffield for clinical studies position Sparrow for accelerated product validation and market entry, offering sales channels through academic institutions and research collaborations.

Clinical Development Priority Active clinical trials such as phase 2 studies for clofutriben and SPI-62 create opportunities to engage with clinical decision-makers and early adopter physicians interested in innovative metabolic and endocrinology therapies.

Market Positioning Operating in a niche with less competition and significant market demand for precision therapies in metabolic disorders allows for targeted marketing strategies and potential partnerships with healthcare providers seeking advanced treatment options.

Sparrow Pharmaceuticals, Inc. Tech Stack

Sparrow Pharmaceuticals, Inc. uses 8 technology products and services including Squarespace Commerce, Google Fonts API, RequireJS, and more. Explore Sparrow Pharmaceuticals, Inc.'s tech stack below.

Squarespace Commerce

E-commerce

Google Fonts API

Font Scripts

RequireJS

Javascript Frameworks

Element UI

Javascript Frameworks

JSON-LD

Javascript Frameworks

Zepto

Javascript Libraries

Choices

Javascript Libraries

HSTS

Security

Sparrow Pharmaceuticals, Inc. Email Formats	Example	Percentage
FLast@sparrowpharma.com	JDoe@sparrowpharma.com	73%
Last@sparrowpharma.com	Doe@sparrowpharma.com	14%
First@sparrowpharma.com	John@sparrowpharma.com	13%

Sparrow Pharmaceuticals, Inc. Email Formats

Example

Percentage

FLast@sparrowpharma.com

JDoe@sparrowpharma.com

73%

Last@sparrowpharma.com

Doe@sparrowpharma.com

14%

First@sparrowpharma.com

John@sparrowpharma.com

13%

Frequently Asked Questions

Where is Sparrow Pharmaceuticals, Inc.'s headquarters located?

Sparrow Pharmaceuticals, Inc.'s main headquarters is located at 75 State Street Suite 100 Boston, Massachusetts United States. The company has employees across 2 continents, including North AmericaEurope.

What is Sparrow Pharmaceuticals, Inc.'s official website and social media links?

Sparrow Pharmaceuticals, Inc.'s official website is sparrowpharma.com and has social profiles on LinkedIn Crunchbase.

What is Sparrow Pharmaceuticals, Inc.'s NAICS code?

Sparrow Pharmaceuticals, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Sparrow Pharmaceuticals, Inc. have currently?

As of May 2026, Sparrow Pharmaceuticals, Inc. has approximately 19 employees across 2 continents, including North AmericaEurope. Key team members include Chief Medical Officer: F. C.Vice President Program Management: A. R.Vp Finance & Administation: C. S.. Explore Sparrow Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Sparrow Pharmaceuticals, Inc. belong to?

Sparrow Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Sparrow Pharmaceuticals, Inc. use?

Sparrow Pharmaceuticals, Inc.'s tech stack includes Squarespace CommerceGoogle Fonts APIRequireJSElement UIJSON-LDZeptoChoicesHSTS.

What is Sparrow Pharmaceuticals, Inc.'s email format?

Sparrow Pharmaceuticals, Inc.'s email format typically follows the pattern of FLast@sparrowpharma.com. Find more Sparrow Pharmaceuticals, Inc. email formats with LeadIQ.

How much funding has Sparrow Pharmaceuticals, Inc. raised to date?

As of May 2026, Sparrow Pharmaceuticals, Inc. has raised $95M in funding. The last funding round occurred on Sep 24, 2025 for $95M.

When was Sparrow Pharmaceuticals, Inc. founded?

Sparrow Pharmaceuticals, Inc. was founded in 2013.

Sparrow Pharmaceuticals, Inc.

Q: What technology does Sparrow Pharmaceuticals, Inc. use?

Sparrow Pharmaceuticals, Inc.'s tech stack includes Google Cloud, X-Content-Type-Options, TweenMax, RequireJS, Element UI.

Q: What is Sparrow Pharmaceuticals, Inc.'s NAICS code?

Sparrow Pharmaceuticals, Inc.'s NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees

Sparrow Pharmaceuticals is a targeted cardiometabolic therapeutics company delivering improved outcomes for millions of patients who struggle to control their disease with current options for diabetes and related metabolic conditions.

The Company’s lead candidate, clofutriben, is a first-in-class, once-daily, oral HSD-1 inhibitor initially in development for type 2 diabetes with elevated cortisol. HSD-1 inhibition targets an underlying etiology of treatment resistance across the spectrum of metabolic dysfunction and is complementary to leading antidiabetic agents.

Sparrow is led by an experienced team of biotech executives, endocrinologists, and drug development veterans with a shared commitment to precision medicine in metabolic disease.

Insights

Similar companies to Sparrow Pharmaceuticals, Inc.

sanofi

Johnson & Johnson

Merck

Pfizer

AstraZeneca

Crinetics Pharmaceuticals

AbbVie

Novartis